Dr. Brian Nahed specializes in Brain Tumors (Glioblastoma, Gliomas, Meningiomas, and Metastatic Brain Tumors) and Spinal Disorders. He is an Assistant Professor and Neurosurgeon in the Department of Neurosurgery and Pappas Center for Neurooncology.
BiographyDr. Brian Nahed specializes in Brain tumors (Glioblastoma, Gliomas, Metastatic Brain Tumors and Meningiomas) and Spinal Disorders. He has clinical appointments in the Brain Tumor and Cancer Center, Stephen E. and Catherine Pappas Center for Neurooncology. He is an Assistant Professor and teaching faculty member of Harvard Medical School and Massachusetts General Hospital.
Dr. Brian Nahed's research focuses on circulating brain tumor cells and metastatic disease. In collaboration with Drs. Daniel Haber and Shyamala Maheswaran, Dr. Nahed's research has received several grants and awards and has been presented at national conferences. Dr. Nahed is actively enrolling patients with brain tumors into his research study. Dr. Brian Nahed is an active member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, and serves on national committees for the Tumor Section and Council of State Neurological Surgeons.
Circulating Brain Tumor Cells
Metastatic Disease of the Brain and Spine
Dr. Brian Nahed's research focuses on identifying and analyzing circulating tumor cells in the blood of patients with brain cancer. Through a collaboration between bioengineers, molecular biologists and clinicians, a circulating tumor cell capture device was developed to capture and detect tumor cells from patients with cancer. Under the mentorship of Drs. Daniel Haber, Shyamala Maheswaran, and Mehmet Toner, they aim to harness this technology to genetically characterize tumor cells without needing an invasive biopsy, and determine responsiveness to targeted cancer drugs. It also offers the opportunity to study cancer stem cells or @ metastasis precursors, thought to be at the origin of cancer spread via the bloodstream, to define their molecular vulnerabilities and help design new therapies to prevent cancer metastasis.
76 peer-reviewed publications to date. Please refer to pub med link below for articles.